World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Defense Diagnostics Inc. to Exhibit DEFENT ONE Fentanyl Detection Device at the 2026 Rx and Illicit Drug Summit

Cision PR Newswire by Cision PR Newswire
April 6, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

The First and Only All-In-One Fentanyl Detection Device Comes to the Nation’s Leading Addiction and Overdose Crisis Conference

LOS ANGELES, April 6, 2026 /PRNewswire/ — Defense Diagnostics Inc. (DDI), a pioneering medical diagnostics company, today announced it will exhibit at the 2026 Rx and Illicit Drug Summit taking place April 6-9 at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee. The company will showcase its flagship product, DEFENT ONE, the first and only all-in-one fentanyl detection device designed to support communities and harm reduction efforts by reducing overdoses and saving lives, at Booth #216 on April 7-8 from 11:45 a.m. – 5:00 p.m. CT.


DEFENT (PRNewsfoto/Defense Diagnostics Inc.)

The Rx and Illicit Drug Summit is the nation’s leading multidisciplinary conference on the opioid and addiction crisis, convening clinicians, public health professionals, first responders, policymakers, and community advocates. This year’s featured speakers include FBI Director Kash Patel and CNN Chief Medical Correspondent Dr. Sanjay Gupta, who will deliver the keynote. While national overdose numbers have started to decline, the crisis is far from over, and DDI’s participation reflects its commitment to advancing practical, deployable prevention tools at a time when that work remains as urgent as ever.

With fentanyl overdoses now the leading cause of death for Americans aged 18-45, the need for accessible, reliable detection has never been more critical. DEFENT ONE is a pocket-sized, single-use device that detects fentanyl and more than 150 of its analogs in under three minutes. Designed for real-world conditions, it requires no additional equipment or specialized training and is discreet enough to be used in any setting – especially social environments where exposure risk is highest. Each device also includes a QR code that allows users to anonymously report positive detections, contributing real-time data to a community-wide effort to identify and flag contaminated drug supplies as they emerge.

“Fentanyl is still killing people at devastating rates, and the communities most affected need real solutions, not just awareness,” said Ahmad Hussain, Founder and CEO of Defense Diagnostics Inc. “Primary prevention has been underinvested in for too long. Opioid settlement funds exist precisely for this purpose, and the Rx Summit is where the people making those decisions come together. We created DEFENT ONE to be accessible and actionable, and we’re bringing it to Nashville to get it in front of the people who can put it to use where it matters most.”

DDI will be available for meetings and product demonstrations during the Summit. To connect with the team or learn more about DEFENT ONE, please visit https://defense-diagnostics.com/ or stop by Booth #216.

Media Contact:
5W Public Relations
DEFENT@5wpr.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/defense-diagnostics-inc-to-exhibit-defent-one-fentanyl-detection-device-at-the-2026-rx-and-illicit-drug-summit-302734204.html

SOURCE DEFENT

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

    0 shares
    Share 0 Tweet 0
  • Mendez & Sanchez Finds Three Counties Accounted for Nearly Two-Thirds of California Rideshare Trips

    0 shares
    Share 0 Tweet 0
  • Highmark Health Reports Revenue of $26.5 billion, $741 million in Operating Income, for Nine Months ended Sept. 30, 2026

    0 shares
    Share 0 Tweet 0
  • AZ Blue Health Choice Expands Access to Resources for Page Families

    0 shares
    Share 0 Tweet 0
  • Payoneer Receives OCC Conditional Approval to Form Stablecoin National Trust Bank

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler